Activities per year
- 10 results
Search results
-
ONI Nanoimager - Analyzing EV Heterogeneity by Super-Resolution Microscopy
Wolf, M. (Invited speaker)
24 May 2024Activity: Talk or presentation › Invited talk
-
Protein corona of EVs is essential for skin cell self organisation and aids wound healing
Wolf, M. (Speaker)
28 Oct 2023Activity: Talk or presentation › Oral presentation
-
Protein corona of EVs is essential for skin self organisation and aids wound healing
Wolf, M. (Speaker)
18 Oct 2023 → 20 Oct 2023Activity: Talk or presentation › Oral presentation
-
Functional implications of protein EV corona
Wolf, M. (Speaker)
5 Sept 2023Activity: Talk or presentation › Oral presentation
-
Essential role of a protein corona around extracellular vesicles in aiding angiogenesis and skin regeneration.
Wolf, M. (Speaker)
2021Activity: Talk or presentation › Oral presentation
-
First evidence for a protein corona around extracellular vesicles playing an essential role in aiding angiogenesis and skin regeneration.
Wolf, M. (Speaker)
2021Activity: Talk or presentation › Oral presentation
-
Enhanced angiogenesis and wound healing in vivo induced by extracellular vesicles from therapeutic grade allogeneic human placental stromal cells.
Wolf, M. (Speaker)
2021Activity: Talk or presentation › Oral presentation
-
Biology & Function of Stromal Cell-derived EVs.
Wolf, M. (Speaker)
2019 → …Activity: Talk or presentation › Oral presentation
-
Proteomic analysis reveals angiogenic and immunomodulatory function for placental stromal cell-derived extracellular vesicles.
Wolf, M. (Speaker)
2019 → …Activity: Talk or presentation › Oral presentation
-
Regeneration of injured tissues requires effective therapeutic strategies supporting vasculogenesis. The lack of instantly available autologous cell sources and immunogenicity of allogeneic endothelial (progenitor) cells limits clinical progress. Based on the immunosuppressive potency of mesenchymal stem/progenitor cells (MSCs), we investigated whether crosstalk between endothelial colony-forming progenitor cells (ECFCs) and MSCs during vasculogenesis could lower allogeneic T cell responses against ECFCs allowing long-term engraftment in vivo. Crosstalk between UC-derived ECFCs and MSCs after combined transplantation can lower the risk of ECFC rejection, thus enabling their coapplication for therapeutic vasculogenesis. Stem Cells 2017;35:1233-1245.
Wolf, M. (Cooperation)
2010Activity: Other scientific activities › Cooperation